Stockholm3 blood test detected 90% of aggressive prostate cancer cases compared to 74% for PSA tests in a study of over 12,000 men in Sweden.

New technologies can potentially save lives by helping identify prostate cancer earlier, and transforming the way doctors detect and track cancerous cells. Prostate cancer is the most common cancer ...

CorePlus, Puerto Rico’s fully digital precision pathology and clinical laboratory, announced today the integration of the ...

Q: I am 77. My brother died of prostate cancer. My doctor says I don’t need PSA testing at my age. But because my brother ...

A new study suggests the investigational Stockholm3 blood test may improve the early detection of aggressive prostate cancer ...

The study's testing accurately identified prostate cancer 91% of the time and accurately ruled out men without prostate cancer 84% of the time. A urine-based biomarker panel may be a promising, ...

NeoGenomics, Inc.(NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced the launch of PTEN IHC CDx, the first immunohistochemistry (IHC) ...

Prostate cancer is the most common cancer in Australia, with about 26,000 men diagnosed per year. The majority (more than 85%) are aged over 60. Prostate cancer kills around 3,900 Australians a year.

Prostate cancer is one of the most common cancers in the world. While many prostate cancers grow slowly and remain localized, other types are aggressive and spread quickly. That's why Dr. Carlos ...

To check for possible prostate cancer, physicians most often use prostate-specific antigen (PSA) tests and digital rectal exams (DREs). For a firm diagnosis, they use core needle biopsies. This page ...

Former President Joe Biden received his last known blood test to check for prostate cancer in 2014, a spokesperson said Tuesday — two days after Biden revealed he has an aggressive form of prostate ...